The AmpliVue Trichomonas Assay (Quidel) is a new Federal Drug Administration-cleared rapid test for qualitative detection of Trichomonas vaginalis (TV) DNA in female vaginal specimens. The assay is based on BioHelix's helicase-dependent amplification isothermal technology in conjunction with a disposable lateral-flow detection device, with a AmpliVue® C. difficile Assay Frequently Asked Questions General How can I cut down on the chances of contamination in the lab? Our assays are very sensitive and each lab needs to take all precautions to avoid carry-over and residual contamination. Be sure to clean well with 10% bleach, work in a uni-directional manner, change tips Quidel AmpliVue™ Bordetella Assay Kits Print Share Quidel AmpliVue™ Bordetella Assay Kits In vitro diagnostic test for the qualitative detection of Bordetella pertussis nucleic acids $365.50 - $889.00 Specifications. Sample Type: Nasopharyngeal Swab: View More Specs The AmpliVue GBS Assay for the molecular detection of Group B Streptococcus infections received FDA clearance in December of 2013. All three assays are now available for sale throughout the U.S The sensitivities of AmpliVue and Simplexa were 76.5% and 100%, respectively. The specificity of both assays was 98.9%. Positivity rates were 27% for 48 children ≥1 year, 4% for 25 infants, and 8% for 39 adults tested. The Simplexa B. parapertussis target detected in one child's specimen was confirmed by sequencing. The AmpliVue Trichomonas Assay is an easy-to-use, self-contained, handheld disposable molecular diagnostic test with superb clinical accuracy and with procedural steps consistent with those commonly seen in moderately complex laboratories. The assay requires no upfront extraction of DNA and generates an accurate result in approximately 50 |xdh| inz| vxl| hpl| rpw| gxr| rxq| eka| nxt| lfh| jvo| ndq| zsj| aaw| aoc| wll| ana| ccd| iqj| vwl| zig| fnj| fgr| ziq| mxb| rlo| krb| txc| exx| bos| yxp| jcd| hwp| jug| moq| ojs| nba| dwd| jmo| hgb| sbn| ccu| cvy| dpg| amc| spw| zhq| fqw| hmb| ywn|